The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer
Open accessAbstract
Objective The role of sentinel lymph node (SLN) biopsy alone for staging of early-stage cervical cancer remains controversial. We aimed to determine the validity of this technique in women with early-stage cervical cancer. Methods We retrospectively reviewed women with early-stage cervical cancer who underwent SLN mapping followed by complete pelvic lymphadenectomy as part of initial surgical management from August 1997 through October 2015. All modes of surgical approach were included. Lymphatic mapping was performed using blue dye, technetium-99m sulfur colloid (Tc-99), and/or indocyanine green (ICG). We determined SLN detection rates, sensitivity and negative predictive value. Results One hundred eighty-eight patients were included, and 35 (19%) had lymph node metastases. At least one SLN was identified in 170 patients (90%), and bilateral SLNs were identified in 117 patients (62%). The majority of SLNs (83%) were found in the pelvis. There was no difference in detection rates between mapping agents, surgical approach, patients with and without prior conization or between patients with tumors < 2 cm and ≥ 2 cm. The detection rate for bilateral SLNs was significantly lower in women with body mass index (BMI) > 30 kg/m2 than in women with lower BMI (p=0.03). Metastatic disease in sentinel nodes was detected by H&E staining in 78% of cases and required ultrastaging/immunohistochemistry in 22% of cases. Only one patient had a false-negative result, yielding a sensitivity of 96.4% (95% CI 79.8%–99.8%) and negative predictive value of 99.3% (95% CI 95.6%–100%). The false-negative rate was 3.6%. Conclusions In these women with early-stage cervical cancer, SLN biopsy had very high sensitivity and negative predictive value. We believe it is time to change the standard of care for women with early-stage cervical cancer to SLN biopsy only.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2008.08.010 · Cited by 51,384
Cited by
Frumovitz, M., Plante, M., Lee, P. S., Sandadi, S., Lilja, J. F., Escobar, P. F., Gien, L. T., Urbauer, D. L., & Abu-Rustum, N. R. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30448-0 · Cited by 349
Self-citation
Metadata
- Authors
- Salvo, G., Ramirez, P. T., Levenback, C. F., Munsell, M. F., Euscher, E. D., Soliman, P. T., & Frumovitz, M.
- Venue
- Gynecologic Oncology
- Publisher
- Elsevier BV
- Published
- 2017-04
- Volume
- 145
- Issue
- 1
- Pages
- 96-101
- ISSN
- 0090-8258 (ISSN-L)
- OpenAlex
- W2587479045
- Cited by
- 190
- References
- 1
- FWCI
- 25.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer. https://app.cochat.ai/papers/10.1016/j.ygyno.2017.02.005
- The paper
- Salvo, G., Ramirez, P. T., Levenback, C. F., Munsell, M. F., Euscher, E. D., Soliman, P. T., & Frumovitz, M. (2017). Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer. Gynecologic Oncology. https://doi.org/10.1016/j.ygyno.2017.02.005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.